Pei Wan

442 total citations
16 papers, 311 citations indexed

About

Pei Wan is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Pei Wan has authored 16 papers receiving a total of 311 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 5 papers in Cancer Research and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Pei Wan's work include Ferroptosis and cancer prognosis (3 papers), Beetle Biology and Toxicology Studies (2 papers) and Renal cell carcinoma treatment (2 papers). Pei Wan is often cited by papers focused on Ferroptosis and cancer prognosis (3 papers), Beetle Biology and Toxicology Studies (2 papers) and Renal cell carcinoma treatment (2 papers). Pei Wan collaborates with scholars based in China, Hong Kong and Finland. Pei Wan's co-authors include Huiming Jiang, Nanhui Chen, Haibin Chen, J. L. Jones, Debra L. Hanson, R. Monina Klevens, Mark S. Dworkin, Patrick S. Sullivan, Wanlong Tan and You Zhou and has published in prestigious journals such as Clinical Infectious Diseases, BioMed Research International and Urology.

In The Last Decade

Pei Wan

15 papers receiving 307 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Pei Wan China	10	107	90	84	78	52	16	311
Dajiang Li China	12	130 1.2×	88 1.0×	62 0.7×	63 0.8×	46 0.9×	23	365
Guiwen Guan China	12	146 1.4×	160 1.8×	138 1.6×	56 0.7×	29 0.6×	28	453
Xianming Liang China	11	171 1.6×	54 0.6×	85 1.0×	128 1.6×	24 0.5×	28	406
Yu‐Kwan Tong Hong Kong	6	107 1.0×	42 0.5×	124 1.5×	77 1.0×	24 0.5×	6	334
Avi S. Retter United States	10	111 1.0×	43 0.5×	80 1.0×	108 1.4×	84 1.6×	20	314
Alberto Molares-Vila Spain	8	126 1.2×	69 0.8×	61 0.7×	37 0.5×	39 0.8×	19	321
Alessia Di Silvestre Italy	9	119 1.1×	66 0.7×	24 0.3×	92 1.2×	23 0.4×	14	284
Tian Fu China	9	205 1.9×	54 0.6×	34 0.4×	142 1.8×	55 1.1×	16	336
Lianying Zhao China	8	207 1.9×	39 0.4×	86 1.0×	120 1.5×	40 0.8×	13	426

Countries citing papers authored by Pei Wan

Since Specialization

Citations

This map shows the geographic impact of Pei Wan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pei Wan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pei Wan more than expected).

Fields of papers citing papers by Pei Wan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pei Wan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pei Wan. The network helps show where Pei Wan may publish in the future.

Co-authorship network of co-authors of Pei Wan

This figure shows the co-authorship network connecting the top 25 collaborators of Pei Wan. A scholar is included among the top collaborators of Pei Wan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pei Wan. Pei Wan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Wan, Pei, Chenxin Xu, Xi Jia, et al.. (2025). Development and clinical validation of a novel protein biomarkers-based algorithm for risk prediction and diagnosis of advanced liver fibrosis: a multi-centre study. Journal of Advanced Research.

Wan, Pei, et al.. (2024). Combination effect of flavonoids attenuates lung cancer cell proliferation by inhibiting the STAT3 and FAK signaling pathway. Open Life Sciences. 19(1). 20220977–20220977. 1 indexed citations

Wan, Pei, et al.. (2021). miR-200a-3p facilitates bladder cancer cell proliferation by targeting the A20 gene. Translational Andrology and Urology. 10(11). 4262–4274. 10 indexed citations

Jiang, Huiming, Haibin Chen, Pei Wan, & Nanhui Chen. (2021). Decreased expression of HADH is related to poor prognosis and immune infiltration in kidney renal clear cell carcinoma. Genomics. 113(6). 3556–3564. 24 indexed citations

Jiang, Huiming, Haibin Chen, Pei Wan, Meng Liang, & Nanhui Chen. (2021). Upregulation of TMEM45A Promoted the Progression of Clear Cell Renal Cell Carcinoma in vitro. Journal of Inflammation Research. Volume 14. 6421–6430. 6 indexed citations

Jiang, Huiming, et al.. (2021). Downregulation of PPA2 expression correlates with poor prognosis of kidney renal clear cell carcinoma. PeerJ. 9. e12086–e12086. 5 indexed citations

Jiang, Huiming, et al.. (2020). Downregulation of enhancer RNA EMX2OS is associated with poor prognosis in kidney renal clear cell carcinoma. Aging. 12(24). 25865–25877. 22 indexed citations

Wan, Pei, Zhilin Chen, Huiming Jiang, et al.. (2020). BRDT is a novel regulator of eIF4EBP1 in renal cell carcinoma. Oncology Reports. 44(6). 2475–2486. 13 indexed citations

Wu, Zhiming, et al.. (2019). Eupatilin Inhibits Renal Cancer Growth by Downregulating MicroRNA-21 through the Activation of YAP1. BioMed Research International. 2019. 1–11. 13 indexed citations

10.

Chen, Sansan, Pei Wan, Wenqi Ding, et al.. (2013). Norcantharidin inhibits DNA replication and induces mitotic catastrophe by degrading initiation protein Cdc6. International Journal of Molecular Medicine. 32(1). 43–50. 14 indexed citations

11.

Chen, Sansan, Pei Wan, Ziyi Wang, et al.. (2013). Norcantharidin Inhibits Pre-Replicative Complexes Assembly of HepG2 Cells. The American Journal of Chinese Medicine. 41(3). 665–682. 14 indexed citations

12.

Li, Fei, You Zhou, Vesa M. Olkkonen, et al.. (2012). Identification of urinary Gc-globulin as a novel biomarker for bladder cancer by two-dimensional fluorescent differential gel electrophoresis (2D-DIGE). Journal of Proteomics. 77. 225–236. 33 indexed citations

13.

Jing, Yuming, Jie Luo, Yanling Zhang, et al.. (2012). [Construction of a recombinant lentiviral vector of p38 MAPK and establishment of a human prostatic carcinoma cell line stably expressing p38 MAPK].. PubMed. 32(3). 317–21. 1 indexed citations

14.

Shi, Xiaojun, Xinji Zhang, Jin‐Long Li, et al.. (2011). Sequential administration of GM-CSF and IL-2 surface-modified MB49 cells vaccines against the metastatic bladder cancer. Urologic Oncology Seminars and Original Investigations. 31(6). 883–893. 9 indexed citations

15.

Li, Fei, Shengli An, You Zhou, et al.. (2011). Milk and Dairy Consumption and Risk of Bladder Cancer: A Meta-analysis. Urology. 78(6). 1298–1305. 49 indexed citations

16.

Dworkin, Mark S., Pei Wan, Debra L. Hanson, et al.. (2000). Aspergillosis among People Infected with Human Immunodeficiency Virus: Incidence and Survival. Clinical Infectious Diseases. 31(5). 1253–1257. 97 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact